| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.25 |
2e-06 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.24 |
7e-06 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.23 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0002 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |